BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 24418657)

  • 21. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation.
    Wu JB; Kuo YH; Lin CH; Ho HY; Shih CC
    J Agric Food Chem; 2014 Nov; 62(44):10717-26. PubMed ID: 25317836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice.
    Ip W; Shao W; Chiang YT; Jin T
    Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1348-58. PubMed ID: 24085036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-Arabinose suppresses gluconeogenesis through modulating AMP-activated protein kinase in metabolic disorder mice.
    Wang Y; Guan Y; Xue L; Liu J; Yang Z; Nie C; Yan Y; Liu S; Sun J; Fan M; Qian H; Ying H; Li Y; Wang L
    Food Funct; 2021 Mar; 12(4):1745-1756. PubMed ID: 33502423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geniposide Suppresses Hepatic Glucose Production via AMPK in HepG2 Cells.
    Guo L; Zheng X; Liu J; Yin Z
    Biol Pharm Bull; 2016; 39(4):484-91. PubMed ID: 26830672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saponarin activates AMPK in a calcium-dependent manner and suppresses gluconeogenesis and increases glucose uptake via phosphorylation of CRTC2 and HDAC5.
    Seo WD; Lee JH; Jia Y; Wu C; Lee SJ
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5237-42. PubMed ID: 26471090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Bofu-Tsusho-San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice.
    Lin CH; Kuo YH; Shih CC
    Int J Mol Sci; 2014 Nov; 15(11):20022-44. PubMed ID: 25375187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes.
    Kim TH; Kim MK; Cheong YH; Chae YN; Lee Y; Ka SO; Jung IH; Shin CY; Bae EJ; Son MH
    Eur J Pharmacol; 2016 Jan; 771():65-76. PubMed ID: 26621343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
    Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
    J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HM-chromanone suppresses hepatic glucose production via activation of AMP-activated protein kinase in HepG2 cell.
    Park JE; Han JS
    Eur J Pharmacol; 2022 Aug; 928():175108. PubMed ID: 35718128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ergostatrien-3β-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-activated protein kinase phosphorylation.
    Kuo YH; Lin CH; Shih CC
    J Agric Food Chem; 2015 Mar; 63(9):2479-89. PubMed ID: 25693659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
    Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
    Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Entada phaseoloides extract suppresses hepatic gluconeogenesis via activation of the AMPK signaling pathway.
    Zheng T; Hao X; Wang Q; Chen L; Jin S; Bian F
    J Ethnopharmacol; 2016 Dec; 193():691-699. PubMed ID: 27742409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
    Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
    Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of hepatic AMPK activation in glucose metabolism and dexamethasone-induced regulation of AMPK expression.
    Viana AY; Sakoda H; Anai M; Fujishiro M; Ono H; Kushiyama A; Fukushima Y; Sato Y; Oshida Y; Uchijima Y; Kurihara H; Asano T
    Diabetes Res Clin Pract; 2006 Aug; 73(2):135-42. PubMed ID: 16503364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceramide enhanced the hepatic glucagon response through regulation of CREB activity.
    Wang J; Wang D; Lu S; Hu Y; Ge Y; Qin X; Mo Y; Kan J; Li D; Zhang R; Liu Y; Zhang WS
    Clin Nutr; 2024 Feb; 43(2):366-378. PubMed ID: 38142481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK.
    Lee YH; Yun MR; Kim HM; Jeon BH; Park BC; Lee BW; Kang ES; Lee HC; Park YW; Cha BS
    Int J Obes (Lond); 2016 Feb; 40(2):356-65. PubMed ID: 26315841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selenite exacerbates hepatic insulin resistance in mouse model of type 2 diabetes through oxidative stress-mediated JNK pathway.
    Zhou J; Xu G; Bai Z; Li K; Yan J; Li F; Ma S; Xu H; Huang K
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):409-18. PubMed ID: 26522834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice.
    Zhou TT; Zhao T; Ma F; Zhang YN; Jiang J; Ruan Y; Yan QY; Wang GH; Ren J; Guan XW; Guo J; Zhao YH; Ye JM; Hu LH; Chen J; Shen X
    Acta Pharmacol Sin; 2019 Sep; 40(9):1193-1204. PubMed ID: 30833709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice.
    Hwang YP; Choi JH; Han EH; Kim HG; Wee JH; Jung KO; Jung KH; Kwon KI; Jeong TC; Chung YC; Jeong HG
    Nutr Res; 2011 Dec; 31(12):896-906. PubMed ID: 22153515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.